Contractor guidance on the Hep C Testing Service

Contractor guidance on the Hep C Testing Service

September 17, 2020

The Community Pharmacy Hepatitis C Antibody Testing Service is the second new Advanced Service to be added to the NHS Community Pharmacy Contractual Framework (CPCF). The service was originally trailed as part of the 5-year CPCF agreement and its implementation was delayed in response to the COVID-19 pandemic outbreak. The service launched on the 1st September 2020.

The service offers a Hepatitis C antibody test in the pharmacy to people who inject drugs (PWID) who are not currently accessing treatment services (e.g. for the management of addiction to opioids). Where people test positive for hepatitis C antibodies, they will be referred for a confirmatory test, followed by treatment, where appropriate.

Any pharmacy that meets the service requirements can provide the service, but it will be of most interest to contractors that provide a locally commissioned needle and syringe programme (NSP) service, with a sufficient number of clients.

PSNC has published a Briefing providing guidance for community pharmacy contractors and their teams on the Community Pharmacy Hepatitis C Antibody Testing Service.

Download the Briefing here.

 



Posted in:


More Latest News >